Difference between revisions of "Team:CPU CHINA"

 
(128 intermediate revisions by 3 users not shown)
Line 3: Line 3:
  
 
<head>
 
<head>
−
    <link rel="stylesheet" href="https://2017.igem.org/Team:CPU_CHINA/css/home?action=raw&amp;ctype=text/css">
+
    <script src="https://cdn.bootcss.com/jquery/1.9.1/jquery.min.js"></script>
 +
    <script src="https://cdn.bootcss.com/onepage-scroll/1.3.1/jquery.onepage-scroll.min.js"></script>
 +
 
 +
    <link rel="stylesheet" href="https://2017.igem.org/Team:CPU_CHINA/css/home?action=raw&amp;ctype=text/css">
 
     <link rel="stylesheet" href="https://2017.igem.org/Team:CPU_CHINA/css/description?action=raw&amp;ctype=text/css">
 
     <link rel="stylesheet" href="https://2017.igem.org/Team:CPU_CHINA/css/description?action=raw&amp;ctype=text/css">
 
</head>
 
</head>
 +
 +
 +
<body>
 +
 +
<script>
 +
$(function(){
 +
$('.body-container').onepage_scroll({
 +
sectionContainer: '.pagee',
 +
loop: false,
 +
pagination: false
 +
});
 +
});
 +
</script>
 +
 +
    <div class="body-container">
 +
 +
            <center class="pagee pagee0" id="dyk">
 +
            <p><br>&nbsp;<br></p>
 +
            <p><br>&nbsp;<br></p>
 +
            <p><br>&nbsp;<br></p>
 +
         
 +
            <img src="https://static.igem.org/mediawiki/2017/9/97/T--CPU_CHINA--mainpage_new.png" width = "1300">
 +
            </center>
 +
 +
            <center class="pagee pagee1">
 +
            <p><br>&nbsp;<br></p>
 +
   
 +
             
 +
            <h5 style="padding: 0px; margin: 5px;">Our HEAD-Treg</h5>
 +
            <video src="https://static.igem.org/mediawiki/2017/5/5a/T--CPU_CHINA--V123.mp4" controls="controls" class="video" width = "55%"></video>
 +
            </center>
 +
 +
            <center class="pagee pagee2">
 +
                <p><br>&nbsp;<br></p>
 +
            <p><br>&nbsp;<br></p>
 +
            <h5 style="padding: 0px; margin: 0px;">Description</h5>
 +
            <h4 style="margin: 5px;">Rheumatoid arthritis (RA) is a serious chronic, inflammatory and systemic autoimmune disease.
 +
                <br>It is of great essence to develop a novel cell-targeted therapy for RA
 +
because there is no radical cure
 +
                    for RA for the time being. <br>To solve the problems existing in the current treatment of RA, we design and build a brand new immunotherapy. <br>FOXP3+ regulatory T cells(Tregs), which can suppress and regulate immune reactions, are modified <br> utilizing a lentiviral vector system to express a chimeric antigen receptor(CAR) targeting inflammatory cells associated with RA.
 +
              <br>Meanwhile, we insert the Syn-Notch receptor to activate the functional stability pathway of Tregs in the
 +
                    inflammatory environment, which enables them to play their role of immunosuppression in lesions more
 +
                    efficiently and more stably. <br>These two redirections of the two different but interrelated systems on Tregs ensure this novel therapy a promising anti-RA effect. </h4>
 +
                          <p><br>&nbsp;<br></p>
 +
                       
 +
<center class="footer-left">
 +
  <p class="footer-links" style="text-align:center;">
 +
<a target="_blank" href="https://www.cpu.edu.cn">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2017/5/52/T--CPU_CHINA--cpu_logo_new_1.png"></a>
 +
<a target="_blank" href="http://www.shsmu.edu.cn/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2017/e/e9/T--CPU_CHINA--cpu_logoJDYXY_NEW.png"></a>
 +
        <a target="_blank" href="http://www.sibs.cas.cn/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2017/0/0d/T--CPU_CHINA--cpu_logo_SIBS.png"></a>
 +
        <a target="_blank" href="http://sii.shsmu.edu.cn/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2017/5/5b/T--CPU_CHINA--cpu_SHMYYJS_NEW.png"></a>
 +
        <a target="_blank" href="http://www.mathwork.com">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2017/2/2b/T--CPU_CHINA--cpu_logo_mathwork.png"></a>
 +
        <a target="_blank" href="https://www.genscript.com/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2017/3/38/T--CPU_CHINA--cpu_logogenscript.png"></a>
 +
        <a target="_blank" href="javascript:();">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2017/d/da/Cyva.jpg"></a>
 +
                                <a target="_blank" href="javascript:();">
 +
                                <img class="sponsors" src="https://static.igem.org/mediawiki/2017/1/17/T--CPU_CHINA--cpu_sponsors_11_contect_2.png"></a>
 +
  </p>
 +
</center>
 +
            </center>
 +
 +
    </div>
 +
 +
 +
</body>
 +
 
<style>
 
<style>
 +
.footer-distributed{
 +
background-color: #f7f5e6;
 +
box-shadow: 0 1px 1px 0 rgba(0, 0, 0, 0.12);
 +
box-sizing: border-box;
 +
width: 100%;
 +
text-align: left;
 +
padding: 45px 50px;
 +
margin-top: 0px;
 +
}
 +
 +
.footer-distributed .footer-left p{
 +
        color:  #52658F;
 +
font-size: 14px;
 +
margin: 0;
 +
}
 +
.footer-distributed .footer-right p{
 +
        color:  #52658F;
 +
font-size: 14px;
 +
margin: 0;
 +
}
 +
 +
/* Footer links */
 +
 +
.footer-distributed p.footer-links{
 +
font-size:18px;
 +
font-weight: bold;
 +
color:  #ffffff;
 +
margin: 0 0 10px;
 +
padding: 0;
 +
}
 +
 +
 +
.footer-distributed p.footer-links a{
 +
display:inline-block;
 +
line-height: 1.8;
 +
text-decoration: none;
 +
color:  inherit;
 +
}
 +
 +
.footer-distributed .footer-right{
 +
float: right;
 +
margin-top: 6px;
 +
max-width: 400px;
 +
}
 +
 +
 +
 +
.footer-distributed .footer-right a{
 +
display: inline-block;
 +
width: 50px;
 +
height: 35px;
 +
background-color:  #33383b;
 +
border-radius: 2px;
 +
 +
font-size: 20px;
 +
color: #52658F;
 +
text-align: center;
 +
line-height: 35px;
 +
 +
margin-left: 3px;
 +
}
 +
 +
.sponsors {
 +
            margin: 2.5px;
 +
            width: 150px;
 +
        }
 +
 +
/* If you don't want the footer to be responsive, remove these media queries */
 +
 +
@media (max-width: 600px) {
 +
 +
.footer-distributed .footer-left,
 +
.footer-distributed .footer-right{
 +
text-align: center;
 +
}
 +
 +
.footer-distributed .footer-right{
 +
float: none;
 +
margin: 0 auto 20px;
 +
}
 +
 +
.footer-distributed .footer-left p.footer-links{
 +
line-height: 1.8;
 +
}
 +
}
 +
</style>
 +
 +
 +
<style>
 +
/* 滑动特效模块需要 */
 
#content{
 
#content{
 
     width: 100%;
 
     width: 100%;
 +
}
 +
h4{line-height:40px;
 +
 +
}
 +
h1,h2,h4{
 +
font-family: "Century Gothic";
 +
}
 +
h3{
 +
font-family: "Times New Roman";
 +
font-size: 40px;
 +
}
 +
.body-container h5 {
 +
font-family: "Comic Sans MS";
 +
font-size: 60px;
 +
text-align: center;
 +
}
 +
 +
 +
body, html {
 +
  margin: 0;
 +
  overflow: hidden;
 +
  -webkit-transition: opacity 400ms;
 +
  -moz-transition: opacity 400ms;
 +
  transition: opacity 400ms;
 +
}
 +
 +
body, .onepage-wrapper, html {
 +
  display: block;
 +
  position: static;
 +
  padding: 0;
 +
  width: 100%;
 +
  height: 100%;
 +
}
 +
 +
.onepage-wrapper {
 +
  width: 100%;
 +
  height: 100%;
 +
  display: block;
 +
  position: relative;
 +
  padding: 0;
 +
  -webkit-transform-style: preserve-3d;
 +
}
 +
 +
.onepage-wrapper .section {
 +
  width: 100%;
 +
  height: 100%;
 +
}
 +
 +
.onepage-pagination {
 +
  position: absolute;
 +
  right: 10px;
 +
  top: 50%;
 +
  z-index: 5;
 +
  list-style: none;
 +
  margin: 0;
 +
  padding: 0;
 +
}
 +
.onepage-pagination li {
 +
  padding: 0;
 +
  text-align: center;
 +
}
 +
.onepage-pagination li a{
 +
  padding: 10px;
 +
  width: 4px;
 +
  height: 4px;
 +
  display: block;
 +
 
 +
}
 +
.onepage-pagination li a:before{
 +
  content: '';
 +
  position: absolute;
 +
  width: 4px;
 +
  height: 4px;
 +
  background: rgba(0,0,0,0.85);
 +
  border-radius: 10px;
 +
  -webkit-border-radius: 10px;
 +
  -moz-border-radius: 10px;
 +
}
 +
 +
.onepage-pagination li a.active:before{
 +
  width: 10px;
 +
  height: 10px;
 +
  background: none;
 +
  border: 1px solid black;
 +
  margin-top: -4px;
 +
  left: 8px;
 +
}
 +
 +
.disabled-onepage-scroll, .disabled-onepage-scroll .wrapper {
 +
  overflow: auto;
 +
}
 +
 +
.disabled-onepage-scroll .onepage-wrapper .section {
 +
  position: relative !important;
 +
  top: auto !important;
 +
  left: auto !important;
 +
}
 +
.disabled-onepage-scroll .onepage-wrapper {
 +
  -webkit-transform: none !important;
 +
  -moz-transform: none !important;
 +
  transform: none !important;
 +
  -ms-transform: none !important;
 +
  min-height: 100%;
 +
}
 +
 +
 +
.disabled-onepage-scroll .onepage-pagination {
 +
  display: none;
 +
}
 +
 +
body.disabled-onepage-scroll, .disabled-onepage-scroll .onepage-wrapper, html {
 +
  position: inherit;
 
}
 
}
 
</style>
 
</style>
−
<body>
 
−
    <div class="body-container" style="padding-left:0">
 
−
            <p class="body-title" style="margin-top:80px">
 
−
                SynNotch CAR-Tregs V.S. Rheumatoid Arthritis
 
−
            </p>
 
−
            <h3>HEAD-Treg</h3>
 
−
            <br><br><img src="https://static.igem.org/mediawiki/2017/5/54/T--CPU_CHINA--home-figure1.jpg" class="img-top"><br><br><br><br><br><br><br><br><br><br>
 
−
            <video src="https://static.igem.org/mediawiki/2017/c/c8/T--CPU_CHINA--video_1.mp4" controls="controls" class="video"></video>
 
−
            <p class="body-title" style="padding-top:100px">Description</p>
 
−
            <div class="content" style="margin-top:60px">
 
−
                <h4>Rheumatoid arthritis (RA) is a serious chronic, inflammatory and systemic autoimmune disease.</h4>
 
−
                <h4>s of great essence to develop a kind of novel cell-targeted therapy for RA because there is no radical cure
 
−
                    for RA for the time being.</h4>
 
−
                <h4>To solve the problems existing in the current treatment of RA, we design and build a brand new immunotherapy.
 
−
                    FOXP3+ regulatory T cells(Tregs), which can suppress and regulate immune reactions, are modified utilizing
 
−
                    a lentiviral vector system to express a chimeric antigen receptor(CAR) targeting inflammatory cells associated
 
−
                    with RA. </h4>
 
−
                <h4> Meanwhile, we insert the Syn-Notch receptor to activate the functional stability pathway of Tregs in the
 
−
                    inflammatory environment, which enables them to play their role of immunosuppression in lesions more
 
−
                    efficiently and more stably.</h4>
 
−
                <h4>These two redirections of the two different but interrelated systems on Tregs ensure this novel therapy a
 
−
                    promising anti-RA effect. </h4>
 
−
            </div>
 
−
            <div class="body-footer">
 
−
                <div class="row logo">
 
−
                    <div class="col-md-4">
 
−
                        <img src="https://static.igem.org/mediawiki/2017/5/5e/T--CPU_CHINA--LOGO_logo1.jpg" alt="">
 
−
                    </div>
 
−
                    <div class="col-md-4">
 
−
                        <img src="https://static.igem.org/mediawiki/2017/8/88/T--CPU_CHINA--LOGO_logo2.png" alt="">
 
−
                    </div>
 
−
                    <div class="col-md-4">
 
−
                        <img src="https://static.igem.org/mediawiki/2017/e/eb/T--CPU_CHINA--LOGO_logo3.jpg" alt="">
 
−
                    </div>
 
−
                </div>
 
−
                <div class="row logo" style="margin-top:20px">
 
−
                    <div class="col-md-4">
 
−
                        <img src="https://static.igem.org/mediawiki/2017/c/c8/T--CPU_CHINA--LOGO_logo4.png" alt="">
 
−
                    </div>
 
−
                    <div class="col-md-4">
 
−
                    </div>
 
−
                    <div class="col-md-4">
 
−
                        <img src="https://static.igem.org/mediawiki/2017/6/62/T--CPU_CHINA--LOGO_logo5.jpg" alt="">
 
−
                    </div>
 
−
                </div>
 
−
                <div class="row else-contact">
 
−
                    <div class="col-md-4">
 
−
                        <span class="foot-title" style="text-indent = 0">Contact Us</span>
 
−
                        <br>
 
−
                        <span class="foot-content">15605170073</span>
 
−
                    </div>
 
−
                    <div class="col-md-4">
 
−
                        <span class="foot-title" style="text-indent = 0">Emial</span>
 
−
                        <br>
 
−
                        <span class="foot-content">467072280@qq.com</span>
 
−
                    </div>
 
−
                    <div class="col-md-4" style="border-right: none">
 
−
                        <span class="foot-title" style="text-indent = 0">Address</span>
 
−
                        <br>
 
−
                        <span class="foot-content">南京航空航天大学</span>
 
−
                    </div>
 
−
                </div>
 
−
            </div>
 
−
        </div>
 
  
  
−
</body>
+
<script type="text/javascript">
 +
!function(e){var t={sectionContainer:"section",easing:"ease",animationTime:1e3,pagination:true,updateURL:false,keyboard:true,beforeMove:null,afterMove:null,loop:true,responsiveFallback:false,direction:"vertical"};e.fn.swipeEvents=function(){return this.each(function(){function i(e){var i=e.originalEvent.touches;if(i&&i.length){t=i[0].pageX;n=i[0].pageY;r.bind("touchmove",s)}}function s(e){var i=e.originalEvent.touches;if(i&&i.length){var o=t-i[0].pageX;var u=n-i[0].pageY;if(o>=50){r.trigger("swipeLeft")}if(o<=-50){r.trigger("swipeRight")}if(u>=50){r.trigger("swipeUp")}if(u<=-50){r.trigger("swipeDown")}if(Math.abs(o)>=50||Math.abs(u)>=50){r.unbind("touchmove",s)}}}var t,n,r=e(this);r.bind("touchstart",i)})};e.fn.onepage_scroll=function(n){function o(){var t=false;var n=typeof r.responsiveFallback;if(n=="number"){t=e(window).width()<r.responsiveFallback}if(n=="boolean"){t=r.responsiveFallback}if(n=="function"){valFunction=r.responsiveFallback();t=valFunction;typeOFv=typeof t;if(typeOFv=="number"){t=e(window).width()<valFunction}}if(t){e("body").addClass("disabled-onepage-scroll");e(document).unbind("mousewheel DOMMouseScroll MozMousePixelScroll");i.swipeEvents().unbind("swipeDown swipeUp")}else{if(e("body").hasClass("disabled-onepage-scroll")){e("body").removeClass("disabled-onepage-scroll");e("html, body, .wrapper").animate({scrollTop:0},"fast")}i.swipeEvents().bind("swipeDown",function(t){if(!e("body").hasClass("disabled-onepage-scroll"))t.preventDefault();i.moveUp()}).bind("swipeUp",function(t){if(!e("body").hasClass("disabled-onepage-scroll"))t.preventDefault();i.moveDown()});e(document).bind("mousewheel DOMMouseScroll MozMousePixelScroll",function(e){e.preventDefault();var t=e.originalEvent.wheelDelta||-e.originalEvent.detail;u(e,t)})}}function u(e,t){deltaOfInterest=t;var n=(new Date).getTime();if(n-lastAnimation<quietPeriod+r.animationTime){e.preventDefault();return}if(deltaOfInterest<0){i.moveDown()}else{i.moveUp()}lastAnimation=n}var r=e.extend({},t,n),i=e(this),s=e(r.sectionContainer);total=s.length,status="off",topPos=0,leftPos=0,lastAnimation=0,quietPeriod=500,paginationList="";e.fn.transformPage=function(t,n,r){if(typeof t.beforeMove=="function")t.beforeMove(r);e(this).css({"-webkit-transform":t.direction=="horizontal"?"translate3d("+n+"%, 0, 0)":"translate3d(0, "+n+"%, 0)","-webkit-transition":"all "+t.animationTime+"ms "+t.easing,"-moz-transform":t.direction=="horizontal"?"translate3d("+n+"%, 0, 0)":"translate3d(0, "+n+"%, 0)","-moz-transition":"all "+t.animationTime+"ms "+t.easing,"-ms-transform":t.direction=="horizontal"?"translate3d("+n+"%, 0, 0)":"translate3d(0, "+n+"%, 0)","-ms-transition":"all "+t.animationTime+"ms "+t.easing,transform:t.direction=="horizontal"?"translate3d("+n+"%, 0, 0)":"translate3d(0, "+n+"%, 0)",transition:"all "+t.animationTime+"ms "+t.easing});e(this).one("webkitTransitionEnd otransitionend oTransitionEnd msTransitionEnd transitionend",function(e){if(typeof t.afterMove=="function")t.afterMove(r)})};e.fn.moveDown=function(){var t=e(this);index=e(r.sectionContainer+".active").data("index");current=e(r.sectionContainer+"[data-index='"+index+"']");next=e(r.sectionContainer+"[data-index='"+(index+1)+"']");if(next.length<1){if(r.loop==true){pos=0;next=e(r.sectionContainer+"[data-index='1']")}else{return}}else{pos=index*100*-1}if(typeof r.beforeMove=="function")r.beforeMove(next.data("index"));current.removeClass("active");next.addClass("active");if(r.pagination==true){e(".onepage-pagination li a"+"[data-index='"+index+"']").removeClass("active");e(".onepage-pagination li a"+"[data-index='"+next.data("index")+"']").addClass("active")}e("body")[0].className=e("body")[0].className.replace(/\bviewing-page-\d.*?\b/g,"");e("body").addClass("viewing-page-"+next.data("index"));if(history.replaceState&&r.updateURL==true){var n=window.location.href.substr(0,window.location.href.indexOf("#"))+"#"+(index+1);history.pushState({},document.title,n)}t.transformPage(r,pos,next.data("index"))};e.fn.moveUp=function(){var t=e(this);index=e(r.sectionContainer+".active").data("index");current=e(r.sectionContainer+"[data-index='"+index+"']");next=e(r.sectionContainer+"[data-index='"+(index-1)+"']");if(next.length<1){if(r.loop==true){pos=(total-1)*100*-1;next=e(r.sectionContainer+"[data-index='"+total+"']")}else{return}}else{pos=(next.data("index")-1)*100*-1}if(typeof r.beforeMove=="function")r.beforeMove(next.data("index"));current.removeClass("active");next.addClass("active");if(r.pagination==true){e(".onepage-pagination li a"+"[data-index='"+index+"']").removeClass("active");e(".onepage-pagination li a"+"[data-index='"+next.data("index")+"']").addClass("active")}e("body")[0].className=e("body")[0].className.replace(/\bviewing-page-\d.*?\b/g,"");e("body").addClass("viewing-page-"+next.data("index"));if(history.replaceState&&r.updateURL==true){var n=window.location.href.substr(0,window.location.href.indexOf("#"))+"#"+(index-1);history.pushState({},document.title,n)}t.transformPage(r,pos,next.data("index"))};e.fn.moveTo=function(t){current=e(r.sectionContainer+".active");next=e(r.sectionContainer+"[data-index='"+t+"']");if(next.length>0){if(typeof r.beforeMove=="function")r.beforeMove(next.data("index"));current.removeClass("active");next.addClass("active");e(".onepage-pagination li a"+".active").removeClass("active");e(".onepage-pagination li a"+"[data-index='"+t+"']").addClass("active");e("body")[0].className=e("body")[0].className.replace(/\bviewing-page-\d.*?\b/g,"");e("body").addClass("viewing-page-"+next.data("index"));pos=(t-1)*100*-1;if(history.replaceState&&r.updateURL==true){var n=window.location.href.substr(0,window.location.href.indexOf("#"))+"#"+(t-1);history.pushState({},document.title,n)}i.transformPage(r,pos,t)}};i.addClass("onepage-wrapper").css("position","relative");e.each(s,function(t){e(this).css({position:"absolute",top:topPos+"%"}).addClass("section").attr("data-index",t+1);e(this).css({position:"absolute",left:r.direction=="horizontal"?leftPos+"%":0,top:r.direction=="vertical"||r.direction!="horizontal"?topPos+"%":0});if(r.direction=="horizontal")leftPos=leftPos+100;else topPos=topPos+100;if(r.pagination==true){paginationList+="<li><a data-index='"+(t+1)+"' href='#"+(t+1)+"'></a></li>"}});i.swipeEvents().bind("swipeDown",function(t){if(!e("body").hasClass("disabled-onepage-scroll"))t.preventDefault();i.moveUp()}).bind("swipeUp",function(t){if(!e("body").hasClass("disabled-onepage-scroll"))t.preventDefault();i.moveDown()});if(r.pagination==true){if(e("ul.onepage-pagination").length<1)e("<ul class='onepage-pagination'></ul>").prependTo("body");if(r.direction=="horizontal"){posLeft=i.find(".onepage-pagination").width()/2*-1;i.find(".onepage-pagination").css("margin-left",posLeft)}else{posTop=i.find(".onepage-pagination").height()/2*-1;i.find(".onepage-pagination").css("margin-top",posTop)}e("ul.onepage-pagination").html(paginationList)}if(window.location.hash!=""&&window.location.hash!="#1"){init_index=window.location.hash.replace("#","");if(parseInt(init_index)<=total&&parseInt(init_index)>0){e(r.sectionContainer+"[data-index='"+init_index+"']").addClass("active");e("body").addClass("viewing-page-"+init_index);if(r.pagination==true)e(".onepage-pagination li a"+"[data-index='"+init_index+"']").addClass("active");next=e(r.sectionContainer+"[data-index='"+init_index+"']");if(next){next.addClass("active");if(r.pagination==true)e(".onepage-pagination li a"+"[data-index='"+init_index+"']").addClass("active");e("body")[0].className=e("body")[0].className.replace(/\bviewing-page-\d.*?\b/g,"");e("body").addClass("viewing-page-"+next.data("index"));if(history.replaceState&&r.updateURL==true){var a=window.location.href.substr(0,window.location.href.indexOf("#"))+"#"+init_index;history.pushState({},document.title,a)}}pos=(init_index-1)*100*-1;i.transformPage(r,pos,init_index)}else{e(r.sectionContainer+"[data-index='1']").addClass("active");e("body").addClass("viewing-page-1");if(r.pagination==true)e(".onepage-pagination li a"+"[data-index='1']").addClass("active")}}else{e(r.sectionContainer+"[data-index='1']").addClass("active");e("body").addClass("viewing-page-1");if(r.pagination==true)e(".onepage-pagination li a"+"[data-index='1']").addClass("active")}if(r.pagination==true){e(".onepage-pagination li a").click(function(){var t=e(this).data("index");i.moveTo(t)})}e(document).bind("mousewheel DOMMouseScroll MozMousePixelScroll",function(t){t.preventDefault();var n=t.originalEvent.wheelDelta||-t.originalEvent.detail;if(!e("body").hasClass("disabled-onepage-scroll"))u(t,n)});if(r.responsiveFallback!=false){e(window).resize(function(){o()});o()}if(r.keyboard==true){e(document).keydown(function(t){var n=t.target.tagName.toLowerCase();if(!e("body").hasClass("disabled-onepage-scroll")){switch(t.which){case 38:if(n!="input"&&n!="textarea")i.moveUp();break;case 40:if(n!="input"&&n!="textarea")i.moveDown();break;case 33:if(n!="input"&&n!="textarea")i.moveUp();break;case 34:if(n!="input"&&n!="textarea")i.moveDown();break;case 36:i.moveTo(1);break;case 35:i.moveTo(total);break;default:return}}})}return false}}(window.jQuery)
 +
</script>
 +
 
 +
<script>
 +
$(document).ready(function(){
 +
document.getElementById('dyk').style.position="relative";
 +
});
 +
document.getElementById('dyk').style.position="relative";
 +
</script>
 +
 
 
</html>
 
</html>

Latest revision as of 03:20, 2 November 2017


 


 


 


 

Our HEAD-Treg


 


 

Description

Rheumatoid arthritis (RA) is a serious chronic, inflammatory and systemic autoimmune disease.
It is of great essence to develop a novel cell-targeted therapy for RA because there is no radical cure for RA for the time being.
To solve the problems existing in the current treatment of RA, we design and build a brand new immunotherapy.
FOXP3+ regulatory T cells(Tregs), which can suppress and regulate immune reactions, are modified
utilizing a lentiviral vector system to express a chimeric antigen receptor(CAR) targeting inflammatory cells associated with RA.
Meanwhile, we insert the Syn-Notch receptor to activate the functional stability pathway of Tregs in the inflammatory environment, which enables them to play their role of immunosuppression in lesions more efficiently and more stably.
These two redirections of the two different but interrelated systems on Tregs ensure this novel therapy a promising anti-RA effect.